argenx SE (LON:0QW0)
London · Delayed Price · Currency is GBP · Price in EUR 734.26
+1.58 (0.22%)
At close: Nov 7, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of 39.3 billion as of November 7, 2025. Its market cap has increased by 53.84% in one year.
Market Cap
39.30B
Enterprise Value
36.39B
Revenue
2.74B
Ranking
n/a
PE Ratio
34.46
Stock Price
734.26
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 97.26M to 39.30B, an increase of 40,308.46%. That is a compound annual growth rate of 69.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 39.30B | 31.21% |
| Dec 31, 2024 | 29.95B | 70.09% |
| Dec 29, 2023 | 17.61B | 3.04% |
| Dec 30, 2022 | 17.09B | 24.91% |
| Dec 31, 2021 | 13.68B | 33.96% |
| Dec 31, 2020 | 10.21B | 96.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 66.53B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |